January 23rd 2023
Rapidly distributing vaccines to at least 1/3 of at-risk populations, in addition to increasing tasting and contact tracing, may adequately stop the spread of mpox.
January 18th 2023
With limited health care infrastructure and large swaths of remote areas, developing countries face difficulties in medical management with these viruses and parasitic diseases.
January 10th 2023
Hong Kong confirmed a case of a man critically ill with avian influenza. On the other side of the world, Colorado is reporting its worst-ever avian flu outbreak among birds of prey.
January 6th 2023
The VIASURE PCR diagnostic is now available under Emergency Use Authorization in laboratories for persons with a suspected mpox infection.
December 31st 2022
This unusual Case Study describes a young woman who
presented with an acute onset of headaches and dizziness and was found to have aseptic meningitis.
Looking to Prevent Lyme Disease
TP-05, a novel, oral therapeutic recently reported topline results from its phase 1 study.
Sleeping Sickness Investigational Therapy Demonstrates up to 95% Efficacy
A single-dose of acoziborole could simplify the treatment of this fatal infection.
When Climate Change Gets Personal: The Expanding Threat of Mosquito Habitats
As someone who lives with the long-term effects of chikungunya, Camillo Mora PhD, sees the expanding habitat of mosquitos and is concerned more people will be exposed to vector-borne illnesses and deal with not only the acute phases of these viruses but also the possibility of long-term health effects they can present.
First Dengue Vaccine Approved in the European Union
The European Commission has approved their first dengue vaccine, Takeda’s TAK-003, as climate change and urbanization contribute to a worldwide rise in dengue incidence.
Lyme Disease Vaccine Shows Antibodies 6 Months after Completion
The investigational shot from Pfizer and Valneva demonstrated higher antibody levels in the three-dose vaccination schedule versus the two-dose vaccination schedule.
FDA Grants Priority Review for Investigational Dengue Vaccine
Takeda’s investigational dengue vaccine TAK-003 is currently under evaluation for preventing any dengue virus serotype in individuals 4-60 years old.
Positive Phase 1 Data Reported for Dengue Antiviral
Dengue is the most prevalent and important mosquito-borne virus in the world. Atea Pharmaceuticals presented positive data for their direct-acting dengue antiviral, AT-752.
A Viral Colonial Legacy: HIV, Monkeypox Emerged Due to Ongoing Colonial Viral Neglect
Similar to HIV, the colonial and postcolonial history is fundamental to the biology of this monkeypox outbreak.
Trial Launching to Study Tecovirimat as Monkeypox Treatment
The AIDS Clinical Trials Group (ACTG) is launching a phase 3 trial to evaluate the safety and efficacy of tecovirimat to treat monkeypox in vulnerable populations.
A Study of HIV and STIs Among People With Monkeypox
Oral Tecovirimat for Monkeypox Proctitis: 2 Case Studies
2 Washington, DC monkeypox patients presented with lesions and proctitis, and were treated with oral tecovirimat.
Can Wastewater Surveillance Predict Monkeypox Cases?
Ongoing wastewater surveillance in San Diego seeks to track and predict monkeypox infection surges.
Next Generation Antimalarial MAB Targets Susceptibility of P falciparum
Next generation antimalarial monoclonal antibody is three times more potent than predecessor in preventing parasitemia, stopping parasite replicating.
Langya Virus Zoonotic Spillover in Eastern China
Langya virus, a new type of henipavirus, was identified in at least 35 people in eastern China. The virus is suspected to have infected shrews before jumping to humans.
In Hopes of Stretching Supplies, FDA Changes How Monkeypox Vaccines are Administered
The agency decided to allow for intradermal injection thus increasing the number of available doses substantially.
CDC, WHO Weigh in on Incidence Trends, Monkeypox Vaccines, Public Health Policies
The federal agency and international organization offer some insights on patient epidemiology, and the high-risk groups that public health officials and clinicians should consider for vaccines and education efforts.
US Declares Monkeypox a National Public Health Emergency
Declaration allows mobilization of funding, resources to address the virus.
New York State, San Francisco Declare Monkeypox Emergencies
Public health officials made the decision after seeing increasing incidence rates.
WHO Declares Monkeypox Virus a Global Health Emergency
Last weekend, the World Health Organization declared the monkeypox viral outbreaks a Public Health Emergency of the International Concern (PHEIC).
Rickettsial Infections Heat Up in the US
With the warmer months in full swing, here are clinical considerations
and strategies for tick-borne infections.
Potential Monkeypox Treatments May Already Exist
As monkeypox cases increase, investigators are turning to smallpox antivirals.
Ghana Confirms Multiple Cases of Deadly Marburg Virus
2 patients died of Marburg virus in the southern Ashanti region of Ghana. Nearly 100 close contacts are now under observation for the infectious disease, which is a cousin of the Ebola virus.
Identifying Monkeypox Viral DNA in Bodily Fluid Samples
Investigators found potentially infectious monkeypox virus DNA in saliva and semen.
Can We Decrease Dengue Transmission by Understanding Climate Factors?
Research shows specific climate elements affect mosquito proliferation and can play a role in predictors of vector activity and insect control interventions.
Monkeypox Symptoms in London Patients Differ from Prior Outbreaks
This first study of the UK’s ongoing monkeypox outbreak reported the clinical and demographic features of 54 confirmed cases.
WHO Emergency Committee Does Not Declare Monkeypox Public Health Emergency
The World Health Organization did not declare monkeypox a global health emergency, instead calling it an “evolving health threat” that requires continued monitoring.
Average Monkeypox Incubation Period is 8.5 Days
Using confirmed monkeypox cases in the Netherlands, investigators estimated the average time from infection to symptom onset was 8.5 days.
CDC, WHO Answer Questions From the Press on Monkeypox
At separate press conferences, the CDC and WHO indicate that containing monkeypox will depend on testing, tracing, and currently available vaccines.
Treating Suspected Monkeypox Patients: What Clinicians Need to Know
CDC Completes County-Level Documentation of 7 Tick-Borne Diseases
The CDC recently compiled surveillance data showing the span and prevalence of 7 major pathogens commonly carried by blacklegged ticks.
2 Clarke Drive Cranbury, NJ 08512